Palvella Therapeutics (PVLA) Non-cash Items (2014 - 2026)
Palvella Therapeutics (PVLA) reported Non-cash Items of $954970.0 for Q1 2026, up 91.54% year-over-year from $498578.0 in Q1 2025, and up 13.07% quarter-over-quarter from $844567.0 in Q4 2025.
Palvella Therapeutics (PVLA) Non-cash Items (2014 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 8 years of Non-cash Items data on file, last reported at $954970.0 in Q1 2026.
- Non-cash Items for Q1 2026 came in at $954970.0, up 91.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $954970.0 (up 91.54% YoY), and the FY2025 annual result was $844567.0, down 64.81% from the prior year.
- Non-cash Items rose to $954970.0 in Q1 2026 per PVLA's latest filing, from $844567.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $2.4 million in Q4 2024 and troughed at $300000.0 in Q4 2023.
- A 4-year average of $892029.1 and a median of $669840.0 in 2025 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2024 and 2025: Non-cash Items soared 700.0% in 2024, then tumbled 64.81% in 2025.
- A 4-year view of Non-cash Items shows it stood at $300000.0 in 2023, then soared by 700.0% to $2.4 million in 2024, then plunged by 64.81% to $844567.0 in 2025, then grew by 13.07% to $954970.0 in 2026.
- Business Quant data shows PVLA's Non-cash Items at $954970.0 in Q1 2026, $844567.0 in Q4 2025, and $669840.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palvella Therapeutics | 1.49 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 954,970.00 |
| Mar 31, 2026 | 954,970.00 |
| Dec 31, 2025 | 844,567.00 |
| Dec 31, 2025 | 844,567.00 |
| Sep 30, 2025 | 669,840.00 |
| Sep 30, 2025 | 669,840.00 |
| Jun 30, 2025 | 576,249.00 |
| Jun 30, 2025 | 576,249.00 |
| Mar 31, 2025 | 498,578.00 |
| Mar 31, 2025 | 498,578.00 |
| Dec 31, 2024 | 2.40 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Dec 31, 2021 | 108,000.00 |
| Dec 31, 2021 | 108,000.00 |
| Dec 31, 2016 | 1.96 Mn |
| Dec 31, 2016 | 1.96 Mn |
| Dec 31, 2015 | 1.21 Mn |
| Dec 31, 2015 | 1.21 Mn |